Thomas is co-founder and Chief Financial Officer of Phenex since the inception of the company in 2002. Thomas has a 20 years track record in the biotech industry and during this time he was involved in numerous transactions including major licensing and asset deals, trade sales, financing rounds and public offerings. Thomas studied business administration and holds a degree from the University of Mannheim, Germany.
Thomas Hoffmann and Dr. Claus Kremoser
Chief Financial Officer / Chief Executive Officer
Dr. Claus Kremoser
Claus is co-founder and Chief Executive Officer of Phenex since its beginning. Before starting Phenex, Claus was VP Corporate Development at LION bioscience where he was involved in its IPO in 2001 and in closing the 100 M US$ bioinformatics transaction with Bayer AG. Before that he was a founding member of Ernst & Young´s Life Science group in Stuttgart where he was the originator of the EY Biotech Report in Germany. Claus has studied biochemistry in Tubingen and Munich and received his PhD in developmental neurobiology at the Max-Planck Institute in Tubingen.